Deutsche Bank today maintained a Buy rating on Biogen (NASDAQ: BIIB) with a price target to $240.00. Deutsche Bank also ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View

Biogen Idec (BIIB) Pops on Strong Tecfidera Rx GrowthApril 29, 2013 10:10 AM Jefferies Lifts Numbers on Biogen (BIIB) Post Q1April 26, 2013 8:03 AM Deutsche Bank Maintains Buy on Biogen (BIIB)April 25, 2013 2:00 PM Biogen Idec, Inc. (BIIB) Tops Q1 EPS by 34c; Boosts FY13 OutlookApril 25, 2013 6:31 AM